Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS, especially if they are obese, are more likely to have an underactive thyroid than women without PCOS.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Certain gene variations are not a major cause of male infertility in Nigerian men.

High BMI worsens hair growth in women with PCOS.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Women with PCOS may be more likely to have gum disease than healthy women.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

Silymarin and metformin together most improved hormone levels and ovulation in women with PCOS.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.